Fibrinogen to albumin ratio as a powerful predictor of the exaggerated morning blood pressure surge in newly diagnosed treatment-naive hypertensive patients

Clinical and Experimental Hypertension : CHE
Mahmut ÖzdemirEmin Asoğlu

Abstract

The exaggerated morning blood pressure surge (MS) is a risk factor for cardiovascular diseases. Inflammation is associated with the pathogenesis of hypertension. We aimed to investigate the association between fibrinogen, albumin, fibrinogen to albumin ratio (FAR), and exaggerated MS, and which of those variables is a better predictor for identifying an exaggerated MS in newly diagnosed treatment-naive hypertensive patients. The study included 249 treatment-naive patients who were newly diagnosed with hypertension in both clinical and ambulatory blood pressure (BP) monitoring measurements. Morning BP was defined as the mean of BPs measured during the first 2 hours after wake-up. The lowest BP was defined as the mean of 3 BP measurements focused on the lowest nighttime computations. The MS was calculated as the morning systolic BP minus the lowest systolic BP. Fibrinogen and albumin levels were measured from venous blood. FAR was obtained by dividing the fibrinogen to the albumin. Patients with higher-value MS had a higher fibrinogen, FAR, and a lower albumin than those with low-value MS. MS was positively correlated with fibrinogen and FAR, and negatively correlated with albumin (for all, p < .001). Fibrinogen, albumin, and FAR...Continue Reading

References

Feb 15, 1988·Biochemical Pharmacology·B Halliwell
Mar 4, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Eric L KnightGary C Curhan
Aug 13, 2003·Circulation·Ramon C HermidaManuel Covelo
Apr 10, 2004·Stroke; a Journal of Cerebral Circulation·Tomasz DziedzicAndrzej Szczudlik
May 12, 2004·Circulation·Maria E OttoVirend Somers
Mar 10, 2010·Hypertension·Yan LiUNKNOWN International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators
Nov 1, 2011·Seminars in Immunopathology·Dimitrios Davalos, Katerina Akassoglou
May 16, 2012·Frontiers in Physiology·Paul D Chantler, Edward G Lakatta
Aug 20, 2014·BioMed Research International·Quynh N DinhSophocles Chrissobolis
Jan 7, 2015·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Roberto M LangJens-Uwe Voigt
Apr 19, 2015·The American Journal of Cardiology·Sae Young JaeBarry A Franklin
Mar 28, 2016·The American Journal of Emergency Medicine·Oğuz KarahanCelal Yavuz
Oct 4, 2017·Journal of breast cancer·Ki-Tae HwangSuzy Kim
Jun 7, 2018·Integrated Blood Pressure Control·Grzegorz BiloGianfranco Parati
Aug 10, 2018·World Journal of Gastroenterology : WJG·Wei-Yu XuXin-Ting Sang
Feb 2, 2019·Revista Española De Cardiología
Feb 28, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Hakan DumanNadir Emlek
Mar 13, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Osman KayapinarAdnan Kaya
Dec 24, 2019·Hypertension·Flávio D Fuchs, Paul K Whelton

❮ Previous
Next ❯

Citations

Oct 5, 2021·International Journal of Clinical Practice·Deniz ÇekiçSelçuk Yaylacı

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.